Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

5.16
BATS BZX Real-Time Price
As of 10:07am ET
 +0.10 / +1.98%
Today’s Change
4.93
Today|||52-Week Range
24.50
-71.37%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close5.06
Today’s open5.04
Day’s range5.04 - 5.19
Volume11,246
Average volume (3 months)1,623,059
Market cap$318.7M
Dividend yield--
Data as of 10:07am ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)-34.46%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.01-0.17%
GLYCGlycoMimetics Inc-0.19-1.68%
AVEOAveo Pharmaceuticals...-0.36-10.32%
ACIUAC Immune Ltd-0.31-2.63%
Data as of 10:07am ET, 10/17/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)$0.12
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts